This article is more than 5 years old. Information may no longer be current.
Worldwide TB research efforts to receive $90 million boost
Click Here to Manage Email Alerts
The CDC is awarding $90 million to a global partnership of researchers who are studying tuberculosis treatment drugs in the United States and other parts of the world.
The partnership was established in 1997 by CDC and is known as the Tuberculosis Trials Consortium. The Consortium is a collaboration of clinical investigators who conduct research about the diagnosis, treatment and prevention of TB infection and disease. The partnership is an example of the focus CDC places on research that is programmatically relevant and that involves domestic and international partners addressing TB-related obstacles in countries hardest hit by the disease.
The Consortium has grown from a small group of grantees in North America and a select few other countries to a worldwide organization. The 2010-2020 research group will include clinical research sites in Brazil, China, Kenya, the Philippines, South Africa, Spain, Uganda and Vietnam. Sites in the United States include research centers in Colorado, New Jersey, New York, North Carolina, Tennessee, Texas and Washington, D.C.
The 20 selected sites will receive awards totaling $9.2 million per year over the next ten years.
To date, the Consortium has conducted nine major trials and 15 sub-studies.